Status:
RECRUITING
Physiologic Effects of Nasal High Flow on Exercise Tolerance in COPD
Lead Sponsor:
University of Miami
Collaborating Sponsors:
American Thoracic Society
Conditions:
COPD
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
This study aims to assess whether to describe the effects of the administration of nasal high flow (NHF) at 70 liters per minute (L/min) in a 6-Minute Walk Test (6-MWT) among Chronic Obstructive Pulmo...
Eligibility Criteria
Inclusion
- Able to consent
- Age 18 years or older
- Diagnosis of COPD
- Ability to ambulate without assistance
- Use of low-flow nasal cannula ≤ 4 L/min or no supplemental oxygen (O2) at all
Exclusion
- Pregnancy
- Being on bedrest
- Inability to consent or cooperate with the study
- Using of \> 4 L/min of supplemental O2 or requiring non-invasive ventilation during the daytime
- Hemodynamic instability (resting heart rate \> 130/minute, systolic blood pressure of ≤ 90 mmHg or ≥ 180 mmHg)
- Metal implants in the thoracic regions (pacemakers, Automatic Implantable Cardioverter Defibrillator (AICD), plates, screws, rods, and disc replacements)
Key Trial Info
Start Date :
December 12 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06578156
Start Date
December 12 2024
End Date
December 31 2027
Last Update
December 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Miami
Miami, Florida, United States, 33136